Shanghai Shyndec Pharmaceutical Co Ltd (600420) — Cash Flow Reinvestment Rate
Shanghai Shyndec Pharmaceutical Co Ltd (600420) has a Cash Flow Reinvestment Rate of 0.14x as of September 2025, reinvesting CN¥67.11 Million (capex CN¥67.11 Million ) from operating cash flow of CN¥486.04 Million. Explore capital reinvestment ratio of Shanghai Shyndec Pharmaceutical Co Ltd to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Shanghai Shyndec Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (2004–2025)
Historical reinvestment intensity for Shanghai Shyndec Pharmaceutical Co Ltd across 22 annual periods. Also explore how large is Shanghai Shyndec Pharmaceutical Co Ltd's balance sheet for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Shanghai Shyndec Pharmaceutical Co Ltd (2004–2025)
Year-by-year capital reinvestment analysis for Shanghai Shyndec Pharmaceutical Co Ltd. For live market cap and broader valuation context, see Shanghai Shyndec Pharmaceutical Co Ltd market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.18x | CN¥305.40 Million | CN¥1.70 Billion | CN¥263.83 Million | ▲ +69.1% |
| 2024 | 0.11x | CN¥239.87 Million | CN¥2.26 Billion | CN¥219.77 Million | ▼ -83.9% |
| 2023 | 0.66x | CN¥1.14 Billion | CN¥1.72 Billion | CN¥357.19 Million | ▲ +209.3% |
| 2022 | 0.21x | CN¥609.88 Million | CN¥2.86 Billion | CN¥307.44 Million | ▼ -31.4% |
| 2021 | 0.31x | CN¥522.58 Million | CN¥1.68 Billion | CN¥521.44 Million | ▼ -17.1% |
| 2020 | 0.38x | CN¥585.79 Million | CN¥1.56 Billion | CN¥377.98 Million | ▲ +16.8% |
| 2019 | 0.32x | CN¥408.42 Million | CN¥1.27 Billion | CN¥403.82 Million | ▼ -30.6% |
| 2018 | 0.46x | CN¥772.95 Million | CN¥1.67 Billion | CN¥399.40 Million | ▲ +523.4% |
| 2017 | 0.07x | CN¥171.94 Million | CN¥2.31 Billion | CN¥168.44 Million | ▼ -79.6% |
| 2016 | 0.36x | CN¥305.85 Million | CN¥838.58 Million | CN¥241.30 Million | ▼ -69.6% |
| 2015 | 1.20x | CN¥271.86 Million | CN¥226.65 Million | CN¥234.52 Million | ▼ -28.0% |
| 2014 | 1.67x | CN¥430.53 Million | CN¥258.51 Million | CN¥430.53 Million | ▼ -32.6% |
| 2013 | 2.47x | CN¥512.62 Million | CN¥207.50 Million | CN¥512.62 Million | ▲ +17.8% |
| 2012 | 2.10x | CN¥405.52 Million | CN¥193.41 Million | CN¥405.52 Million | ▲ +122.3% |
| 2011 | 0.94x | CN¥128.40 Million | CN¥136.12 Million | CN¥128.40 Million | ▼ -30.4% |
| 2010 | 1.36x | CN¥156.02 Million | CN¥115.11 Million | CN¥156.02 Million | ▲ +322.0% |
| 2009 | 0.32x | CN¥31.29 Million | CN¥97.43 Million | CN¥31.29 Million | ▲ +37.5% |
| 2008 | 0.23x | CN¥13.56 Million | CN¥58.04 Million | CN¥13.56 Million | ▼ -44.2% |
| 2007 | 0.42x | CN¥34.45 Million | CN¥82.31 Million | CN¥34.45 Million | ▼ -50.3% |
| 2006 | 0.84x | CN¥62.00 Million | CN¥73.60 Million | CN¥62.00 Million | ▼ -31.9% |
| 2005 | 1.24x | CN¥71.65 Million | CN¥57.90 Million | CN¥71.65 Million | ▲ +33.4% |
| 2004 | 0.93x | CN¥15.79 Million | CN¥17.02 Million | CN¥15.79 Million | — |